| Date | Title (click to read) |
|---|---|
| February 15, 2012 | NPS Pharmaceuticals Reports 2011 Year-End Financial Results and 2012 Cash Burn Guidance |
| February 8, 2012 | NPS Pharmaceuticals to Report 2011 Financial Results |
| February 6, 2012 | NPS Pharmaceuticals to Present at Upcoming Conferences |
| January 31, 2012 | NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for GATTEX® (teduglutide) for the Treatment of Adult Short Bowel Syndrome (SBS) |
| January 5, 2012 | NPS Pharmaceuticals to Present at J.P. Morgan Healthcare Conference |
For a complete list of press releases, click here »
Notice to Readers
The reports filed by NPS with the Securities and Exchange Commission and the news releases issued by NPS and posted on this website are current only as of the dates on which they were filed or issued by NPS. Therefore, the contents of these reports and releases can become outdated. We make no commitment, and disclaim any duty, to update these reports and releases. We do not warrant the accuracy or completeness of these materials or the reliability of any advice, opinion, statement or other information displayed or distributed through the website. Readers acknowledge that any reliance on these reports, releases, advice, opinions, statements, or information are at the reader's sole risk.
Stay Informed
To stay apprised of NPS Pharmaceuticals financial reports and SEC filings as they are posted, sign up for Financial Alerts or SEC Alerts via email notification.